208 related articles for article (PubMed ID: 35500608)
21. Preservation of retinoblastoma group E eyes with neovascular glaucoma using intravenous chemotherapy: risk factors and outcomes.
Rao R; Honavar SG; Reddy VP
Br J Ophthalmol; 2019 Dec; 103(12):1856-1861. PubMed ID: 30796055
[TBL] [Abstract][Full Text] [Related]
22. Re: Tomar et al.: American Joint Committee on Cancer Ophthalmic Oncology Task Force. High-risk pathologic features based on presenting findings in advanced intraocular retinoblastoma: a multicenter, international data-sharing American Joint Committee on Cancer Study (Ophthalmology. 2022;129:923-932) and Tomar et al.: American Joint Committee on Cancer Ophthalmic Oncology Task Force. Metastatic death based on presenting features and treatment for advanced intraocular retinoblastoma: a multicenter registry-based study. (Ophthalmology. 2022;129:933-945).
Abramson DH; Shields CL
Ophthalmology; 2023 Mar; 130(3):e11-e12. PubMed ID: 36443123
[No Abstract] [Full Text] [Related]
23. Eye-Preserving Therapies for Advanced Retinoblastoma: A Multicenter Cohort of 1678 Patients in China.
Zhou C; Wen X; Ding Y; Ding J; Jin M; Liu Z; Wang S; Han M; Yuan H; Xiao Y; Wu L; Wang J; Li Y; Yu J; Wen Y; Ye J; Liu R; Chen Z; Xue S; Lu W; Liao H; Cui J; Zhu D; Lu F; Tang S; Wu Y; Yangkyi T; Zhang G; Wubuli M; Guo H; Wang X; He Y; Sheng X; Wang Q; Luo Y; Fan J; Qi J; Yu Z; Tan J; Liang J; Sun X; Jin L; Yang X; Zhang J; Ji X; Zhao J; Jia R; Fan X
Ophthalmology; 2022 Feb; 129(2):209-219. PubMed ID: 34536465
[TBL] [Abstract][Full Text] [Related]
24. Multicenter, International Assessment of the Eighth Edition of the American Joint Committee on Cancer Cancer Staging Manual for Conjunctival Melanoma.
Jain P; Finger PT; Damato B; Coupland SE; Heimann H; Kenawy N; Brouwer NJ; Marinkovic M; Van Duinen SG; Caujolle JP; Maschi C; Seregard S; Pelayes D; Folgar M; Yousef YA; Krema H; Gallie B; Calle-Vasquez A;
JAMA Ophthalmol; 2019 Aug; 137(8):905-911. PubMed ID: 31169891
[TBL] [Abstract][Full Text] [Related]
25. A 20-year audit of retinoblastoma treatment outcomes.
Gündüz AK; Mirzayev I; Temel E; Ünal E; Taçyıldız N; Dinçaslan H; Köse SK; Özalp Ateş FS; Işık MU
Eye (Lond); 2020 Oct; 34(10):1916-1924. PubMed ID: 32376976
[TBL] [Abstract][Full Text] [Related]
26. High-risk features in primary versus secondary enucleated globes with advanced retinoblastoma: a retrospective histopathological study.
Alkatan HM; Al-Dahmash SA; Almesfer SA; AlQahtani FS; Maktabi AMY
Int Ophthalmol; 2020 Nov; 40(11):2875-2887. PubMed ID: 32632618
[TBL] [Abstract][Full Text] [Related]
27. Bilateral advanced (group D or E) intraocular retinoblastoma: outcomes in 72 Asian Indian patients.
Kaliki S; Mittal P; Mohan S; Chattannavar G; Jajapuram SD; Mohamed A; Palkonda VAR
Eye (Lond); 2019 Aug; 33(8):1297-1304. PubMed ID: 30932036
[TBL] [Abstract][Full Text] [Related]
28. Does vitreous haemorrhage and calcification lead to increased risk of enucleation in advanced retinoblastoma?
He M; Yang L; Jia S; Yang J; Wen X; Fan J; Jia R; Fan X
Acta Ophthalmol; 2024 May; 102(3):e296-e301. PubMed ID: 37431955
[TBL] [Abstract][Full Text] [Related]
29. Intra-Arterial Chemotherapy for Retinoblastoma: A Single-Center Experience.
Akyüz C; Kıratlı H; Şen H; Aydın B; Tarlan B; Varan A
Ophthalmologica; 2015; 234(4):227-32. PubMed ID: 26368674
[TBL] [Abstract][Full Text] [Related]
30. A Narrative Review - Therapy Options and Therapy Failure in Retinoblastoma.
Chronopoulos A; Babst N; Schiemenz C; Schutz JS; Heindl LM; Ranjbar M; Kakkassery V
Neurosignals; 2022 Nov; 30(S1):39-58. PubMed ID: 36354963
[TBL] [Abstract][Full Text] [Related]
31. The Predictive Value of the Eighth Edition of the Clinical TNM Staging System for the Likelihood of Eye Salvage for Intraocular Retinoblastoma by Systemic Chemotherapy and Focal Therapy.
Yousef YA; Mohammad M; Mehyar M; Sultan I; Al-Hussaini M; Alhourani J; Halalsheh H; Khzouz J; Jaradat I; Qaddoumi I; Al-Nawaiseh I
J Pediatr Hematol Oncol; 2021 Aug; 43(6):e841-e847. PubMed ID: 33769386
[TBL] [Abstract][Full Text] [Related]
32. Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC.
Abramson DH; Fabius AW; Issa R; Francis JH; Marr BP; Dunkel IJ; Gobin YP
PLoS One; 2015; 10(12):e0145436. PubMed ID: 26709699
[TBL] [Abstract][Full Text] [Related]
33. Targeted chemotherapy in retinoblastoma: A step forward from patient survival to globe survival.
Naseripour M; Sedaghat A; Mirshahi R; Abdolalizadeh P; Koushki A; Faranoush M; Ghorbani M; Kashkouli MB; Sadeghipour A; Chaibakhsh S; Mehrvar A
Eur J Ophthalmol; 2023 Jan; 33(1):574-586. PubMed ID: 35414292
[TBL] [Abstract][Full Text] [Related]
34. Management of retinoblastoma in older children (>5 years) using intra-arterial chemotherapy: Comparison of outcomes to prechemotherapy and intravenous chemotherapy eras.
Selzer EB; Welch RJ; Jabbour P; Leahey AM; Shields CL
Indian J Ophthalmol; 2019 Dec; 67(12):2005-2011. PubMed ID: 31755439
[TBL] [Abstract][Full Text] [Related]
35. Retinoblastoma Control With Primary Intra-arterial Chemotherapy: Outcomes Before and During the Intravitreal Chemotherapy Era.
Shields CL; Alset AE; Say EA; Caywood E; Jabbour P; Shields JA
J Pediatr Ophthalmol Strabismus; 2016 Sep; 53(5):275-84. PubMed ID: 27486728
[TBL] [Abstract][Full Text] [Related]
36. Delayed Enucleation With Neoadjuvant Chemotherapy in Advanced Intraocular Unilateral Retinoblastoma: AHOPCA II, a Prospective, Multi-Institutional Protocol in Central America.
Luna-Fineman S; Chantada G; Alejos A; Amador G; Barnoya M; Castellanos ME; Fu L; Fuentes-Alabi S; Girón V; Goenz MA; Maldonado C; Méndez G; Morales RA; Ortiz R; Sanchez G; Wilson M; Rodríguez-Galindo C
J Clin Oncol; 2019 Nov; 37(31):2875-2882. PubMed ID: 31536438
[TBL] [Abstract][Full Text] [Related]
37. Correlating somatic copy number alteration in aqueous humour cfDNA with chemotherapy history, eye salvage and pathological features in retinoblastoma.
Luo Y; Xu M; Yang L; Yao Y; Berry JL; Xu L; Wen X; He X; Han M; Fan X; Fan J; Jia R
Br J Ophthalmol; 2024 Feb; 108(3):449-456. PubMed ID: 36931696
[TBL] [Abstract][Full Text] [Related]
38. Causes of chemoreduction failure in retinoblastoma and analysis of associated factors leading to eventual treatment with external beam radiotherapy and enucleation.
Gündüz K; Günalp I; Yalçindağ N; Unal E; Taçyildiz N; Erden E; Geyik PO
Ophthalmology; 2004 Oct; 111(10):1917-24. PubMed ID: 15465557
[TBL] [Abstract][Full Text] [Related]
39. High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes.
Fabian ID; Stacey AW; Chowdhury T; Duncan C; Karaa EK; Scheimberg I; Reddy MA; Sagoo MS
Ophthalmology; 2017 Jun; 124(6):851-858. PubMed ID: 28302322
[TBL] [Abstract][Full Text] [Related]
40. Long-term (20-year) real-world outcomes of intravenous chemotherapy (chemoreduction) for retinoblastoma in 964 eyes of 554 patients at a single centre.
Shields CL; Bas Z; Tadepalli S; Dalvin LA; Rao R; Schwendeman R; Lally SE; Shields JA; Shah A; Leahey A
Br J Ophthalmol; 2020 Nov; 104(11):1548-1555. PubMed ID: 32051141
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
